Beta2-agonists Prevent Th1 Development by Selective Inhibition of Interleukin 12

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1997 Sep 18

PMID 9294119

Citations 107

Authors

P Panina-Bordignon

D Mazzeo

P D Lucia

D DAmbrosio

R Lang

L Fabbri

C Self

F Sinigaglia

Affiliations

Soon will be listed here.

Abstract

Interleukin 12 (IL-12) plays a central role in the immune system by skewing the immune response towards T helper 1 (Th1) type responses which are characterized by high interferon-gamma and low IL-4 production. In this report we present evidence that beta2-agonists inhibit IL-12 production by both human monocytes in response to lipopolysaccharide (LPS) and dendritic cells stimulated via CD40. Inhibition of IL-12 production is selective, as other cytokines produced by monocytes are unaffected. IL-12 inhibition is dependent on beta2-adrenoceptor stimulation and correlates with increased levels of intracellular cAMP. In conjunction with their ability to suppress IL-12 production, when beta2-agonists are added at priming of neonatal T lymphocytes, they inhibit the development of Th1-type cells, while promoting T helper 2 (Th2) cell differentiation. Further, the in vivo administration of a therapeutic dose of salbutamol results in the selective inhibition of IL-12 production by whole blood lymphocytes stimulated in vitro with LPS. These findings provide new insight into the immunological consequences of the clinical use of beta2-agonists and may suggest new approaches for the treatment of Th1-mediated diseases.

Citing Articles

Bidirectional regulation of the brain-gut-microbiota axis following traumatic brain injury.

You X, Niu L, Fu J, Ge S, Shi J, Zhang Y Neural Regen Res. 2024; 20(8):2153-2168.

PMID: 39359076 PMC: 11759007. DOI: 10.4103/NRR.NRR-D-24-00088.

Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies.

Hong S, Lai C, Teng N, Chen C, Hsu C, Chan N Front Med (Lausanne). 2023; 10:1105894.

PMID: 37144032 PMC: 10151496. DOI: 10.3389/fmed.2023.1105894.

Immune modulation after traumatic brain injury.

Bouras M, Asehnoune K, Roquilly A Front Med (Lausanne). 2022; 9:995044.

PMID: 36530909 PMC: 9751027. DOI: 10.3389/fmed.2022.995044.

Adrenergic signaling regulation of macrophage function: do we understand it yet?.

Freire B, de Melo F, Basso A Immunother Adv. 2022; 2(1):ltac010.

PMID: 36284839 PMC: 9585663. DOI: 10.1093/immadv/ltac010.

Review of potential medical treatments for middle ear cholesteatoma.

Schurmann M, Goon P, Sudhoff H Cell Commun Signal. 2022; 20(1):148.

PMID: 36123729 PMC: 9487140. DOI: 10.1186/s12964-022-00953-w.

References

Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G . Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol. 1996; 26(3):659-68. DOI: 10.1002/eji.1830260323. View

Hilkens C, Snijders A, VerMeulen H, van der Meide P, Wierenga E, Kapsenberg M . Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells. J Immunol. 1996; 156(5):1722-27. View

Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E . High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med. 1996; 184(2):741-6. PMC: 2192732. DOI: 10.1084/jem.184.2.741. View

Cella M, Scheidegger D, Lane P, Lanzavecchia A, Alber G . Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 1996; 184(2):747-52. PMC: 2192696. DOI: 10.1084/jem.184.2.747. View

Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B . Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods. 1996; 196(2):137-51. DOI: 10.1016/0022-1759(96)00078-6. View

Abbas A, Murphy K, Sher A . Functional diversity of helper T lymphocytes. Nature. 1996; 383(6603):787-93. DOI: 10.1038/383787a0. View

Reinhold M, Lindberg F, Kersh G, Allen P, Brown E . Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med. 1997; 185(1):1-11. PMC: 2211576. DOI: 10.1084/jem.185.1.1. View

Holt P, Sly P . Allergic respiratory disease: strategic targets for primary prevention during childhood. Thorax. 1997; 52(1):1-4. PMC: 1758399. DOI: 10.1136/thx.52.1.1. View

Ma X, Gri G, Gerosa F, Trinchieri G . Immunomodulatory functions and molecular regulation of IL-12. Chem Immunol. 1997; 68:1-22. DOI: 10.1159/000058687. View

10.

Recalde H . A simple method of obtaining monocytes in suspension. J Immunol Methods. 1984; 69(1):71-7. DOI: 10.1016/0022-1759(84)90278-3. View

11.

Jonkman J, Freie H, van der Boon W, Grasmeijer G . Single dose absorption profiles and bioavailability of two different salbutamol tablets. Arzneimittelforschung. 1986; 36(7):1133-5. View

12.

Abel E, DiCicco L, Orenberg E, Fraki J, Farber E . Drugs in exacerbation of psoriasis. J Am Acad Dermatol. 1986; 15(5 Pt 1):1007-22. DOI: 10.1016/s0190-9622(86)70265-x. View

13.

Gallati H, Pracht I, Schmidt J, Haring P, Garotta G . A simple, rapid and large capacity ELISA for biologically active native and recombinant human IFN gamma. J Biol Regul Homeost Agents. 1987; 1(3):109-18. View

14.

Mosmann T, Coffman R . TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989; 7:145-73. DOI: 10.1146/annurev.iy.07.040189.001045. View

15.

Kobayashi M, Fitz L, Ryan M, Hewick R, Clark S, Chan S . Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989; 170(3):827-45. PMC: 2189443. DOI: 10.1084/jem.170.3.827. View

16.

Le Gros G, Ben-Sasson S, Seder R, Finkelman F, Paul W . Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med. 1990; 172(3):921-9. PMC: 2188542. DOI: 10.1084/jem.172.3.921. View

17.

Stern A, Podlaski F, Hulmes J, Pan Y, Quinn P, Wolitzky A . Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci U S A. 1990; 87(17):6808-12. PMC: 54627. DOI: 10.1073/pnas.87.17.6808. View

18.

Swain S, Weinberg A, English M, Huston G . IL-4 directs the development of Th2-like helper effectors. J Immunol. 1990; 145(11):3796-806. View

19.

Steinman R . The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991; 9:271-96. DOI: 10.1146/annurev.iy.09.040191.001415. View

20.

Severn A, Rapson N, Hunter C, Liew F . Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol. 1992; 148(11):3441-5. View